This is a Validated Antibody Database (VAD) review about bovine CD14, based on 110 published articles (read how Labome selects the articles), using CD14 antibody in all methods. It is aimed to help Labome visitors find the most suited CD14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (M5E2)
  • other; human; loading ...; fig 4b
BioLegend CD14 antibody (BioLegend, 301855) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 3a). Am J Respir Crit Care Med (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 5). Front Immunol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:200; loading ...; fig 1b
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...; fig 2d
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on rhesus macaque samples (fig 2d). J Virol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; loading ...; fig 1j
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples at 1:100 (fig 1j). Front Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD14 antibody (BioLegend, 301824) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, 301802) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 2c). Nat Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD14 antibody (Biolegend, 301818) was used in flow cytometry on human samples (fig 6a). Front Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD14 antibody (Biolegend, 301804) was used in flow cytometry on human samples (fig 1c). Cell Death Dis (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on African green monkey samples (fig 2a). Immunology (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 5a
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend CD14 antibody (biolegend, M5E2) was used in flow cytometry on human samples (fig 5a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6b
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 6b). PLoS ONE (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 7a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 7a). Leuk Lymphoma (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD14 antibody (BioLegend, 301811) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:50; loading ...; fig s2b
In order to define the transcriptional network specifies conferring microglia identity, BioLegend CD14 antibody (BioLegend, 301811) was used in flow cytometry on human samples at 1:50 (fig s2b). Science (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3g
In order to map the lineage of human dendritic cells, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 3g). Science (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4
BioLegend CD14 antibody (Biologend, M5E2) was used in flow cytometry on human samples (fig s4). Cell Death Dis (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2
In order to identify cells that respond to interferon lambda, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 2). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, 301804) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, 301804) was used in flow cytometry on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (M5E2)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, BioLegend CD14 antibody (Biolegend, M5E2) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1b). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 2
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend CD14 antibody (Biolegend, 301808) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301808) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on mouse samples . J Virol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig s5
In order to identify the response to anti-MPO antibodies in the form of increased surface expression of ANCA autoantigens and IL-1beta secretion acting as intermediate monocytes in ANCA vasculitis, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig s5). Sci Rep (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig S2
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD14 antibody (biolegend, 301831) was used in flow cytometry on human samples (fig S2). PLoS Pathog (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; fig 3
BioLegend CD14 antibody (Biolegend, 301814) was used in flow cytometry on human samples at 1:100 (fig 3). Nat Commun (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301820) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on rhesus macaque samples . J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig S1
  • immunocytochemistry; human
In order to discuss blood gammadeltaT subsets and their potential role in cancer immunotherapy, BioLegend CD14 antibody (BioLegend, 301806) was used in flow cytometry on human samples (fig S1) and in immunocytochemistry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1
In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1). Exp Gerontol (2014) ncbi
Invitrogen
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Invitrogen CD14 antibody (Invitrogen, TÜK4) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; loading ...; fig 1a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen CD14 antibody (Invitrogen, MA 1-82074) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, Invitrogen CD14 antibody (Invitrogen, T??k4) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; 1:800
In order to develop a system to determine human DC development and differentiation, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples at 1:800. J Immunol Methods (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD14 antibody (Life Technologies, TUK4) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, Invitrogen CD14 antibody (Invitrogen, TK4) was used in flow cytometry on human samples (fig 1). Nat Immunol (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to test if mesenchymal stromal cells support the growth and survival of leukemic stem cells in vitro, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . Stem Cell Res (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to evaluate immune responses by monocyte isolated from young and old adults before and after influenza vaccination, Invitrogen CD14 antibody (Life Technologies, TuK4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, Invitrogen CD14 antibody (Life Technologies, Tuk4) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to examine various DC after flu vaccination, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to investigate the progression of innate responses to mycobacteria in infants, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to study NK function in solid tumors, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to examine the function of NK- and T-cells in order to understand how chronic myeloid leukemia patients maintain the treatment response after IFN-alpha discontinuation, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to study mucosal associated invariant T cells and B cell interactions, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples (fig 1). Front Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; 1:10; fig 4
In order to investigate the cytotoxicity of acyl glucuronide, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples at 1:10 (fig 4). Drug Metab Dispos (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 3
In order to determine the role of conventional and regulatory T cells in protection from HIV-1 infection, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 3). AIDS Res Hum Retroviruses (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to measure and characterize T/NK precursors among CD34(+)Lin(-) cell populations circulating in normal human adult peripheral blood, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 1). J Immunol (2013) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human; fig 1
In order to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in immunocytochemistry on human samples (fig 1). Hum Gene Ther (2013) ncbi
mouse monoclonal (T K4)
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD14 antibody (Invitrogen, T?uK4) was used . J Immunol (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to examine the role of IL-17A-producing multifunctional T cells in the pathogenesis of toxic shock syndrome, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Clin Immunol (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to study B cell populations in patients with N-methyl-D-aspartate receptor encephalitis, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 1). Dev Med Child Neurol (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to explore the multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD14 antibody (Invitrogen, clone TUK4) was used in flow cytometry on human samples (fig 1). Vaccine (2012) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 3
In order to discuss how co-infections and secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic infection, Invitrogen CD14 antibody (InVitrogen, TuK4) was used in flow cytometry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human
In order to discuss the use of umbilical cord blood as a source of transplantable hematopoietic stem cells, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in immunocytochemistry on human samples . Transfusion (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; rhesus macaque; fig 1
In order to characterize different macaque NK cell subpopulations, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on rhesus macaque samples (fig 1). Immunology (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 2
In order to describe a 15-year-old male with longitudinally extensive transverse myelitis with magnetic resonance imaging findings of oedema, cavitation, and gadolinium enhancement, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 2). Dev Med Child Neurol (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 4
In order to test if anti-CD8 Abs induce effector function, Invitrogen CD14 antibody (Caltag, clone Tuk4) was used in flow cytometry on human samples (fig 4). J Immunol (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples (fig 1). Mol Ther (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD14 antibody (Invitrogen, clone TUK4) was used in flow cytometry on human samples (fig 1). Vaccine (2011) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human
In order to discuss the use of internal antigens to provide better protection against multiple influenza subtypes, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in immunocytochemistry on human samples . Clin Infect Dis (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; 1:40; fig 3
In order to investigate targeting CEACAM6 for treatment of pancreatic adenocarcinomas, Invitrogen CD14 antibody (CalTag, clone TUK 4) was used in flow cytometry on human samples at 1:40 (fig 3). J Pathol (2009) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 4
In order to test if leukocyte Ig-like receptor A2 regulates DC differentiation using a leprosy model, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 4). J Immunol (2007) ncbi
mouse monoclonal (T K4)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD14 antibody (Caltag Laboratories, TuK4) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen CD14 antibody (Caltag Laboratories, TUK4) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD14 antibody (Zymed, TUK4) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 4
In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 4). J Virol (2003) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to describe a protocol for the isolation HSC from human fetal liver, Invitrogen CD14 antibody (Caltag, T??K4) was used in flow cytometry on human samples . Biol Proced Online (2002) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to determine of proinflammatory cytokine responses induced by certain bacterial protein adhesins are dependent on TLRs, Invitrogen CD14 antibody (Caltag, Tuk4) was used in flow cytometry on human samples . Clin Diagn Lab Immunol (2002) ncbi
mouse monoclonal (T K4)
  • flow cytometry; rhesus macaque
In order to examine the innate and adaptive immune responses of rhesus macaques infected with SIVmac251, Invitrogen CD14 antibody (BioSource, Tuk4) was used in flow cytometry on rhesus macaque samples . J Virol (2000) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD14 antibody (Caltag, Tuk4) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human; fig 2
In order to describe the cellular composition and organization of lymphoid aggregates in the stratum basalis of uterine endometrium, Invitrogen CD14 antibody (Caltag, TUK 4) was used in immunocytochemistry on human samples (fig 2). J Leukoc Biol (1997) ncbi
Bio-Rad
mouse monoclonal (TUK4)
  • flow cytometry; bovine; fig s1
Bio-Rad CD14 antibody (AbD Serotec, MCA1568A647T) was used in flow cytometry on bovine samples (fig s1). Vet Res (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; tbl 1
Bio-Rad CD14 antibody (AbD Serotec, MCA1568F) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...
Bio-Rad CD14 antibody (AbD Serotec, MCA1568F) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; cat; 1:50; tbl 3
Bio-Rad CD14 antibody (AbD Serotec, MCA1568T) was used in flow cytometry on cat samples at 1:50 (tbl 3). Cell Reprogram (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; domestic rabbit; fig 8
Bio-Rad CD14 antibody (AbD Serotec, MCA1568PB) was used in flow cytometry on domestic rabbit samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
Bio-Rad CD14 antibody (AbD Serotec, MCA1568PE) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
Bio-Rad CD14 antibody (Serotec, MCA1568PE) was used in flow cytometry on human samples . Nanomedicine (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; bovine; loading ...; fig 3c
Bio-Rad CD14 antibody (Serotec, MCA1568) was used in flow cytometry on bovine samples (fig 3c). Theriogenology (2014) ncbi
Novus Biologicals
mouse monoclonal (M5E2)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2a
Novus Biologicals CD14 antibody (Novus Biological, M5E2) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2a). PLoS ONE (2020) ncbi
Articles Reviewed
  1. Gherardini J, Uchida Y, Hardman J, Chéret J, Mace K, Bertolini M, et al. Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo. PLoS ONE. 2020;15:e0227817 pubmed publisher
  2. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  3. Allden S, Ogger P, Ghai P, McErlean P, Hewitt R, Toshner R, et al. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;: pubmed publisher
  4. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  5. Oda H, Beck D, Kuehn H, Sampaio Moura N, Hoffmann P, Ibarra M, et al. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC. Front Immunol. 2019;10:479 pubmed publisher
  6. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  7. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed publisher
  8. Mouhadeb O, Ben Shlomo S, Cohen K, Farkash I, Gruber S, Maharshak N, et al. Impaired COMMD10-Mediated Regulation of Ly6Chi Monocyte-Driven Inflammation Disrupts Gut Barrier Function. Front Immunol. 2018;9:2623 pubmed publisher
  9. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  10. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  11. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  12. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  13. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  14. Nieto C, Bragado R, Municio C, Sierra Filardi E, Alonso B, Escribese M, et al. The Activin A-Peroxisome Proliferator-Activated Receptor Gamma Axis Contributes to the Transcriptome of GM-CSF-Conditioned Human Macrophages. Front Immunol. 2018;9:31 pubmed publisher
  15. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  16. Holbrook B, Aycock S, Machiele E, Clemens E, Gries D, Jorgensen M, et al. An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates. Immunology. 2018;153:357-367 pubmed publisher
  17. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  18. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  19. Lee J, Tam H, Adler L, Ilstad Minnihan A, Macaubas C, Mellins E. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS ONE. 2017;12:e0183594 pubmed publisher
  20. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  21. Ichii M, Oritani K, Murase M, Komatsu K, Yamazaki M, Kyoden R, et al. Molecular targeting of inosine-5'-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway. Leuk Lymphoma. 2018;59:448-459 pubmed publisher
  22. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  23. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  24. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  25. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  26. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  27. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  28. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  29. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  30. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  31. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  32. Andresen V, Erikstein B, Mukherjee H, Sulen A, Popa M, Sørnes S, et al. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis. 2016;7:e2497 pubmed publisher
  33. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  34. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  35. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  36. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  37. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  38. Zhang G, Liu H, Huang J, Chen S, Pan X, Huang H, et al. TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer. Oncotarget. 2016;7:40508-40517 pubmed publisher
  39. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  40. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  41. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  42. Jensen K, Gallagher I, Kaliszewska A, Zhang C, Abejide O, Gallagher M, et al. Live and inactivated Salmonella enterica serovar Typhimurium stimulate similar but distinct transcriptome profiles in bovine macrophages and dendritic cells. Vet Res. 2016;47:46 pubmed publisher
  43. Zwolak A, Słabczyńska O, Semeniuk J, Daniluk J, Szuster Ciesielska A. Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. PLoS ONE. 2016;11:e0150233 pubmed publisher
  44. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  45. Zwolak A, Szuster Ciesielska A, Daniluk J, Słabczyńska O, Kandefer Szerszeń M. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLoS ONE. 2015;10:e0143851 pubmed publisher
  46. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  47. Gómez M, Qin Q, Biancardi M, Galiguis J, Dumas C, MacLean R, et al. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue. Cell Reprogram. 2015;17:376-92 pubmed publisher
  48. Granja T, Schad J, Schüssel P, Fischer C, Häberle H, Rosenberger P, et al. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions. Thromb Res. 2015;136:786-96 pubmed publisher
  49. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  50. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  51. O Brien E, Abdulahad W, Rutgers A, Huitema M, O Reilly V, Coughlan A, et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Sci Rep. 2015;5:11888 pubmed publisher
  52. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  53. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  54. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  55. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  56. Xue J, Sharma V, Hsieh M, Chawla A, Murali R, Pandol S, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158 pubmed publisher
  57. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  58. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  59. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed publisher
  60. Boutard B, Vankerckhove S, Markine Goriaynoff N, Sarlet M, Desmecht D, McFadden G, et al. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. PLoS ONE. 2015;10:e0118806 pubmed publisher
  61. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  62. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed publisher
  63. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  64. Li H, Evans T, Gillis J, Connole M, Reeves R. Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae. J Infect Dis. 2015;211:1717-25 pubmed publisher
  65. Tungatt K, Bianchi V, Crowther M, Powell W, Schauenburg A, Trimby A, et al. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol. 2015;194:463-74 pubmed publisher
  66. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed publisher
  67. Crooks M, Fahim A, Naseem K, Morice A, Hart S. Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor. PLoS ONE. 2014;9:e111347 pubmed publisher
  68. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  69. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  70. Gaffney A, Santos Martinez M, Satti A, Major T, Wynne K, Gun ko Y, et al. Blood biocompatibility of surface-bound multi-walled carbon nanotubes. Nanomedicine. 2015;11:39-46 pubmed publisher
  71. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  72. Fisher J, Yan M, Heuijerjans J, Carter L, Abolhassani A, Frosch J, et al. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells. Clin Cancer Res. 2014;20:5720-32 pubmed publisher
  73. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  74. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  75. Düvel A, Maaß J, Heppelmann M, Hussen J, Koy M, Piechotta M, et al. Peripheral blood leukocytes of cows with subclinical endometritis show an altered cellular composition and gene expression. Theriogenology. 2014;81:906-17 pubmed publisher
  76. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed publisher
  77. Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, et al. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-? monotherapy. PLoS ONE. 2014;9:e87794 pubmed publisher
  78. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  79. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed publisher
  80. Pattacini L, Murnane P, Kahle E, Bolton M, Delrow J, Lingappa J, et al. Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. AIDS Res Hum Retroviruses. 2013;29:1321-9 pubmed publisher
  81. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Imai K, Hayashi T, et al. Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells. J Immunol. 2013;190:6164-72 pubmed publisher
  82. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed publisher
  83. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed publisher
  84. McArthur M, Sztein M. Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol. 2013;146:140-52 pubmed publisher
  85. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  86. Dale R, Pillai S, Brilot F. Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol. 2013;55:191-3 pubmed publisher
  87. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed publisher
  88. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  89. Lyke K, Dabo A, Arama C, Daou M, Diarra I, Wang A, et al. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium. PLoS ONE. 2012;7:e31647 pubmed publisher
  90. Barcena A, Muench M, Kapidzic M, Gormley M, Goldfien G, Fisher S. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011;51 Suppl 4:94S-105S pubmed publisher
  91. Vargas Inchaustegui D, Demberg T, Robert Guroff M. A CD8?(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology. 2011;134:326-40 pubmed publisher
  92. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  93. Dale R, Tantsis E, Merheb V, Brilot F. Cerebrospinal fluid B-cell expansion in longitudinally extensive transverse myelitis associated with neuromyelitis optica immunoglobulin G. Dev Med Child Neurol. 2011;53:856-860 pubmed publisher
  94. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  95. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed publisher
  96. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  97. Berthoud T, Hamill M, Lillie P, Hwenda L, Collins K, Ewer K, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011;52:1-7 pubmed publisher
  98. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed publisher
  99. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  100. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  101. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  102. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  103. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  104. Muench M, Suskind D, Barcena A. Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver. Biol Proced Online. 2002;4:10-23 pubmed
  105. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  106. Hajishengallis G, Martin M, Sojar H, Sharma A, Schifferle R, DeNardin E, et al. Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction. Clin Diagn Lab Immunol. 2002;9:403-11 pubmed
  107. Giavedoni L, Velasquillo M, Parodi L, Hubbard G, Hodara V. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol. 2000;74:1648-57 pubmed
  108. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  109. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  110. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed